High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel

被引：17

作者：

Abali, H ^{[1
]}

Çelik, I ^{[1
]}

机构：

[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, Ankara, Turkey

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2002年 / 25卷 / 06期

关键词：

D O I：

10.1097/00000421-200212000-00023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：632 / 633

页数：2

共 6 条

[1] Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors:: 5-year follow-up results of French adjuvant study group 05 randomized trial
Adenis, A
Bonneterre, J
Bonneterre, ME
Pion, JM
Vanlemmens, L
Gladieff, L
de Lafontan, B
Martel, P
Mihura, J
Roché, H
Gédouin, D
Kerbrat, P
Lesimple, T
Brémond, A
Devaux, Y
Delecroix, V
Fumoleau, P
Maugard-Louboutin, C
Namer, M
Goudier, MJ
Morice, F
Montcuquet, P
Schraub, S
Coudert, B
Fargeot, P
de Gislain, C
Mayer, F
Bastit, P
Chevallier, B
Grandgirard, A
Monnier, A
Sun, X
Clavère, P
Ollivier, JP
Rhein, B
Roullet, B
Datchary, J
Audhuy, B
Barats, JC
Kohser, F
Dides, S
Ramos, R
Cattan, A
Eymard, JC
Pourny, C
Weber, B
de Laroche, G
Pichon, A
Seffert, P
Hayat, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) : 602 - 611
[2] ARNDT CAS, 1988, CANCER RES, V48, P2113
[3] High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel
Crivellari, D
Pagani, O
Veronesi, A
Lombardi, D
Nolè, F
Thürlimann, B
Hess, D
Borner, M
Bauer, J
Martinelli, G
Graffeo, R
Sessa, C
Goldhirsch, A
[J]. ANNALS OF ONCOLOGY, 2001, 12 (03) : 353 - 356
[4] The taxanes: an update
Crown, J
O'Leary, M
[J]. LANCET, 2000, 355 (9210) : 1176 - 1178
[5] TSUKADA Y, 1983, CANCER-AM CANCER SOC, V52, P2349, DOI 10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO
[6] 2-B